Gentaur Monalizumab – Anti-KLRC1 / NKG2A / CD159a Antibody

Gentaur Monalizumab – Anti-KLRC1 / NKG2A / CD159a Antibody

Recognizes inhibitory receptors on NK and CD8+ T-cells. Used to study immune evasion mechanisms in cancer and viral infection models.

$ 1.234.567,00 1234567.0 USD $ 1.234.567,00

$ 1.234.567,00

Diese Kombination existiert nicht.

In den Warenkorb

Geschäftsbedingungen
30-Tage-Geld-zurück-Garantie
Versand: 2-3 Geschäftstage